Literature DB >> 8189239

Extracellular N-acetylaspartate in the rat brain: in vivo determination of basal levels and changes evoked by high K+.

D L Taylor1, S E Davies, T P Obrenovitch, J Urenjak, D A Richards, J B Clark, L Symon.   

Abstract

The purpose of this study was to determine the extracellular concentrations of N-acetylaspartate (NAA) in the rat cerebral cortex, striatum, and hippocampus of halothane-anaesthetised rats by intracerebral microdialysis, and to examine the effects of high K(+)-induced local depolarisation, which provokes synchronous neurotransmitter release, cell swelling, and acid-base changes. Basal levels of NAA in the extracellular fluid (ECF) were determined by the zero net flux method. Tissue levels of NAA in the cortex, striatum, and hippocampus were 8.4, 5.7, and 7.2 mmol/kg, respectively. The corresponding extracellular concentrations of NAA were much lower (35.1, 83.7, and 23.0 microM). High tissue/ECF concentration ratios may suggest little release or leakage of NAA under basal conditions, and potent reuptake mechanisms for NAA in the cellular membrane of CNS cells. There was no change in ECF NAA during K(+)-induced local depolarising stimuli produced in the striatum, but NAA levels consistently increased after the K+ stimuli, irrespective of whether or not Ca2+ was present in the perfusion medium. These data confirm that NAA is not a neurotransmitter and suggest strongly that NAA is not directly involved in the release and reuptake or metabolism of neuroactive compounds. The increase of NAA in the ECF immediately after K+ stimulation may reflect an involvement in brain osmoregulation and/or acid-base homeostasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189239     DOI: 10.1046/j.1471-4159.1994.62062349.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Whole-Brain N-Acetylaspartate Concentration Is Preserved during Mild Hypercapnia Challenge.

Authors:  S Chawla; Y Ge; H Lu; O Marshall; M S Davitz; G Fatterpekar; B J Soher; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-20       Impact factor: 3.825

2.  Reversed-phase HPLC with UV detection for the determination of N-acetylaspartate and creatine.

Authors:  Mattias Tranberg; Malin H Stridh; Barbro Jilderos; Stephen G Weber; Mats Sandberg
Journal:  Anal Biochem       Date:  2005-03-30       Impact factor: 3.365

3.  Newfound effect of N-acetylaspartate in preventing and reversing aggregation of amyloid-beta in vitro.

Authors:  Jean-Pierre Dollé; Jeffrey M Rodgers; Kevin D Browne; Thomas Troxler; Feng Gai; Douglas H Smith
Journal:  Neurobiol Dis       Date:  2018-05-31       Impact factor: 5.996

Review 4.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

5.  Overview of microdialysis.

Authors:  T S Shippenberg; A C Thompson
Journal:  Curr Protoc Neurosci       Date:  2001-05

Review 6.  A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.

Authors:  Caroline D Rae
Journal:  Neurochem Res       Date:  2013-11-21       Impact factor: 3.996

7.  Stimulation-induced transient changes in neuronal activity, blood flow and N-acetylaspartate content in rat prefrontal cortex: a chemogenetic fMRS-BOLD study.

Authors:  Morris H Baslow; Christopher K Cain; Robert Sears; Donald A Wilson; Alvin Bachman; Scott Gerum; David N Guilfoyle
Journal:  NMR Biomed       Date:  2016-10-03       Impact factor: 4.044

8.  Long-term follow-up after gene therapy for canavan disease.

Authors:  Paola Leone; David Shera; Scott W J McPhee; Jeremy S Francis; Edwin H Kolodny; Larissa T Bilaniuk; Dah-Jyuu Wang; Mitra Assadi; Olga Goldfarb; H Warren Goldman; Andrew Freese; Deborah Young; Matthew J During; R Jude Samulski; Christopher G Janson
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956

9.  Hypoosmolarity induces an increase of extracellular N-acetylaspartate concentration in the rat striatum.

Authors:  S E Davies; M Gotoh; D A Richards; T P Obrenovitch
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

10.  Upregulation of N-acetylaspartic acid alters inflammation, transcription and contractile associated protein levels in the stomach and smooth muscle contractility.

Authors:  Sankar Surendran
Journal:  Mol Biol Rep       Date:  2007-10-18       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.